Marshall Fordyce
2023
In 2023, Marshall Fordyce earned a total compensation of $3.4M as President and Chief Executive Officer at Vera Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $32,450 |
|---|---|
| Non-Equity Incentive Plan | $292,050 |
| Option Awards | $2,519,595 |
| Salary | $585,638 |
| Total | $3,429,733 |
Fordyce received $2.5M in option awards, accounting for 73% of the total pay in 2023.
Fordyce also received $32.5K in bonus, $292.1K in non-equity incentive plan and $585.6K in salary.
Rankings
In 2023, Marshall Fordyce's compensation ranked 233rd out of 2,647 executives tracked by ExecPay. In other words, Fordyce earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 233 out of 2,647 | 91st |
Division Manufacturing | 125 out of 1,447 | 91st |
Major group Chemicals And Allied Products | 89 out of 817 | 89th |
Industry group Drugs | 87 out of 783 | 89th |
Industry Pharmaceutical Preparations | 54 out of 555 | 90th |
Source: SEC filing on April 3, 2024.
Fordyce's colleagues
We found two more compensation records of executives who worked with Marshall Fordyce at Vera Therapeutics in 2023.